prokinetics

prokinetics

drugs which enhance the passage of intraluminal contents of the gastrointestinal tract.
References in periodicals archive ?
104) Prokinetics stimulate the MMC, symptomatically correcting this underlying cause.
A rectal probe was inserted and the patient was given prokinetics to facilitate intestinal peristalsis and steroids to reduce the inflammation.
To get a more effective treatment, antidepressant effect and monoaminergic mechanism of Fructus Aurantii (FRA) in the rat forced swimming test (FST) and open field test (OFT), and its prokinetics were examined.
2] receptor blockade by antidopaminergic gastrointestinal prokinetics.
30) Non-operative strategies such as PCD and conservative medical therapies such as sedation, analgesia, neuromuscular blockade, nasogastric and rectal decompression and prokinetics were utilised in more than 70% of our patients, (31) but the majority (>50%) nevertheless required surgical intervention later on.
The benefits of other interventions such as prokinetics, sucralfate, antidepressants and psychological therapy remain unclear.
Al-Juburi advised using an aggressive step-down approach with a combination of prokinetics.
A review of the literature shows that prokinetics, in general, have yet to be tested for their potential effects on non-acid GER.
TZP-101 has a novel mechanism of acting as an agonist of the body's ghrelin receptors, whereas other known gastrointestinal (GI) prokinetics act on serotonin receptors and have been linked to life-threatening cardiac side effects related to QT interval prolongation resulting in their restriction or removal from the market.
Diet along with prokinetics are needed to prevent relapse of this commonly recurring condition.
For gastrointestinal transit, DA-9701 caused FITC-dextran to travel a significantly longer distance than the control, and in the delayed GI transit models induced by laparotomy and atopine, DA-9701 considerably increased the values of mean geometric center (MGC), while the conventional prokinetics rarely showed significant effects.
A second presentation ("Optimized Motilin Agonist Prokinetics," Abstract #DR-0158) describes the approach employed by Kosan scientists to design safe and effective motilin agonists.